Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Iron
Drug ID BADD_D01197
Description A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.
Indications and Usage Used in preventing and treating iron-deficiency anemia.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB01592
KEGG ID Not Available
MeSH ID D007501
PubChem ID 23925
TTD Drug ID D0Y3TM
NDC Product Code 0220-2054; 62106-5042; 68428-383; 64117-791; 0220-2051; 0164-1152
UNII E1UOL152H7
Synonyms Iron | Iron-56 | Iron 56
Chemical Information
Molecular Formula Fe
CAS Registry Number 7439-89-6
SMILES [Fe]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ileal ulcer07.04.06.008--
Impaired gastric emptying07.02.02.0040.000453%
Impaired healing08.03.02.001---
Incontinence07.01.06.011; 17.05.01.006; 20.02.02.004---
Infection11.01.08.002---
Influenza like illness08.01.03.0100.000997%
Injection site bruising08.02.03.042; 12.07.03.042; 23.03.11.015; 24.07.06.017---
Injection site erythema08.02.03.001; 12.07.03.001; 23.03.06.015---
Injection site extravasation08.02.03.002; 12.07.03.002---
Injection site haematoma08.02.03.004; 12.07.03.004; 24.07.01.009---
Injection site haemorrhage08.02.03.005; 12.07.03.005; 24.07.01.0100.001224%-
Injection site mass08.02.03.009; 12.07.03.0100.001224%-
Injection site pain08.02.03.010; 12.07.03.0110.002992%-
Injection site pruritus08.02.03.013; 12.07.03.014; 23.03.12.007---
Injection site rash08.02.03.032; 12.07.03.032; 23.03.13.010---
Injection site reaction08.02.03.014; 12.07.03.015--
Injection site urticaria08.02.03.029; 10.01.06.003; 12.07.03.029; 23.04.02.003---
Insomnia17.15.03.002; 19.02.01.0020.001224%
Intestinal obstruction07.13.01.0020.000453%-
Intestinal perforation07.04.06.0020.000453%-
Intestinal stenosis07.13.01.0030.000453%-
Iron deficiency14.13.02.0020.000453%-
Iron deficiency anaemia01.03.01.002; 14.13.02.0010.001360%-
Jaundice01.06.04.004; 09.01.01.004; 23.03.03.0300.000453%-
Joint stiffness15.01.02.003---
Joint swelling15.01.02.0040.000453%-
Lacrimation increased06.08.02.004--
Laryngeal oedema10.01.05.003; 22.04.02.001; 23.04.01.0050.000453%
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.0040.000453%
Leukocytosis01.02.01.002--
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 14 Pages